+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Hypertension Market and Competitive Landscape - 2020

  • ID: 5023462
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Hypertension Market and Competitive Landscape - 2020, provides comprehensive insights into the Hypertension pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Hypertension market size and drug sales. It also provides insights into Hypertension epidemiology and late stage pipeline.

This research covers the following: Hypertension treatment options, Hypertension late stage clinical trials pipeline, Hypertension prevalence by countries, Hypertension market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Hypertension pipeline: Find out drugs in clinical trials for the treatment of Hypertension by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Hypertension epidemiology: Find out the number of patients diagnosed (prevalence) with Hypertension by countries
  • Hypertension drugs: Identify key drugs marketed and prescribed for Hypertension in the US, including trade name, molecule name, and company
  • Hypertension drugs sales: Find out the sales value for Hypertension drugs by countries
  • Hypertension market valuations: Find out the market size for Hypertension drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Hypertension drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Hypertension drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Hypertension market
  • Develop in-depth knowledge of competition and markets
  • Analyze Hypertension drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Hypertension market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Hypertension Treatment Options

2. Hypertension Pipeline Insights
2.1. Hypertension Phase 3 Clinical Trials
2.2. Hypertension Phase 2 Clinical Trials
2.3. Hypertension Phase 1 Clinical Trials

3. Hypertension Epidemiology Analysis by Countries

4. Germany Hypertension Market Insights
4.1. Marketed Drugs for Hypertension in Germany
4.2. Germany Hypertension Market Size & Forecast
4.3. Germany Hypertension Drugs Sales Forecast
4.4. Germany Hypertension Market Share Analysis

5. France Hypertension Market Insights
5.1. Marketed Drugs for Hypertension in France
5.2. France Hypertension Market Size & Forecast
5.3. France Hypertension Product Sales Forecast
5.4. France Hypertension Market Share Analysis

6. Italy Hypertension Market Insights
6.1. Marketed Drugs for Hypertension in Italy
6.2. Italy Hypertension Market Size & Forecast
6.3. Italy Hypertension Product Sales Forecast
6.4. Italy Hypertension Market Share Analysis

7. Spain Hypertension Market Insights
7.1. Marketed Drugs for Hypertension in Spain
7.2. Spain Hypertension Market Size & Forecast
7.3. Spain Hypertension Product Sales Forecast
7.4. Spain Hypertension Market Share Analysis

8. UK Hypertension Market Insights
8.1. Marketed Drugs for Hypertension in UK
8.2. UK Hypertension Market Size & Forecast
8.3. UK Hypertension Product Sales Forecast
8.4. UK Hypertension Market Share Analysis

9. Europe Hypertension Market Insights
9.1. Europe Hypertension Market Size & Forecast
9.2. Europe Hypertension Product Sales Forecast
9.3. Europe Hypertension Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Hypertension Phase 3 Clinical Trials, Global, 2020
Table 2: Hypertension Phase 2 Clinical Trials, Global, 2020
Table 3: Hypertension Phase 1 Clinical Trials, Global, 2020
Table 4: Hypertension Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Hypertension in Germany, 2019
Table 6: Germany Hypertension Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Hypertension Product Sales ($mn), 2016 - 2024
Table 8: Germany Hypertension Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Hypertension in France, 2019
Table 10: France Hypertension Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Hypertension Product Sales ($mn), 2016 - 2024
Table 12: France Hypertension Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Hypertension in Italy, 2019
Table 14: Italy Hypertension Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Hypertension Product Sales ($mn), 2016 - 2024
Table 16: Italy Hypertension Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Hypertension in Spain, 2019
Table 18: Spain Hypertension Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Hypertension Product Sales ($mn), 2016 - 2024
Table 20: Spain Hypertension Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Hypertension in UK, 2019
Table 22: UK Hypertension Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Hypertension Product Sales ($mn), 2016 - 2024
Table 24: UK Hypertension Market Events and Trends, 2016 - 2024
Table 25: Europe Hypertension Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Hypertension Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Hypertension Pipeline by Phase (%), Global, 2020
Figure 2: Hypertension Prevalence by Countries, 2016 - 2024
Figure 3: Germany Hypertension Market Size ($mn), 2016 - 2024
Figure 4: Germany Hypertension Product Sales ($mn), 2016 - 2024
Figure 5: Germany Hypertension Market Share by Drugs (%), 2019
Figure 6: Germany Hypertension Market - Future Market Share (%), 2024
Figure 7: France Hypertension Market Size ($mn), 2016 - 2024
Figure 8: France Hypertension Product Sales ($mn), 2016 - 2024
Figure 9: France Hypertension Market Share by Drugs (%), 2019
Figure 10: France Hypertension Market - Future Market Share (%), 2024
Figure 11: Italy Hypertension Market Size ($mn), 2016 - 2024
Figure 12: Italy Hypertension Product Sales ($mn), 2016 - 2024
Figure 13: Italy Hypertension Market Share by Drugs (%), 2019
Figure 14: Italy Hypertension Market - Future Market Share (%), 2024
Figure 15: Spain Hypertension Market Size ($mn), 2016 - 2024
Figure 16: Spain Hypertension Product Sales ($mn), 2016 - 2024
Figure 17: Spain Hypertension Market Share by Drugs (%), 2019
Figure 18: Spain Hypertension Market - Future Market Share (%), 2024
Figure 19: UK Hypertension Market Size ($mn), 2016 - 2024
Figure 20: UK Hypertension Product Sales ($mn), 2016 - 2024
Figure 21: UK Hypertension Market Share by Drugs (%), 2019
Figure 22: UK Hypertension Market - Future Market Share (%), 2024
Figure 23: Europe Hypertension Market Size ($mn), 2016 - 2024
Figure 24: Europe Hypertension Product Sales ($mn), 2016 - 2024
Figure 25: Europe Hypertension Market Share by Drugs (%), 2019
Figure 26: Europe Hypertension Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll